New Strategies for the Treatment of Atrial Fibrillation

Related Experiment Video

Updated: Oct 18, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K

Norbert Jost1,2,3, Torsten Christ4,5, János Magyar6,7

  • 1Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, 6725 Szeged, Hungary.

Pharmaceuticals (Basel, Switzerland)
|September 28, 2021
PubMed

Insights

Atrial fibrillation (AF) involves complex atrial remodeling, impacting its persistence. Understanding these electrical, contractile, and structural changes is key to developing new treatments for this common heart rhythm disorder.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) is the most common cardiac arrhythmia, particularly in older adults.
  • AF significantly increases morbidity and mortality rates in the elderly population.
  • Basic research over 25-30 years has elucidated the link between AF pathophysiology and atrial remodeling.

Purpose of the Study:

  • To review and discuss the latest scientific understanding of atrial remodeling in AF.
  • To highlight novel concepts and potential pharmacological targets for AF treatment.

Main Methods:

  • Review of current literature on atrial remodeling in AF.
  • Discussion of the roles of electrical, contractile, and structural remodeling.
  • Identification of potential therapeutic targets.

Main Results:

  • Atrial remodeling (electrical, contractile, structural) is crucial for initiating and maintaining persistent AF.
  • Mechanisms include rapid ectopic firing from pulmonary veins and re-entry circuits.
  • Novel concepts and pharmacological targets for AF treatment are identified.

Conclusions:

  • Atrial remodeling is central to the pathophysiology of atrial fibrillation.
  • Targeting remodeling processes offers promising avenues for future AF drug therapies.

Keywords:
antifibrillatory drugsatrial electrical remodellingatrial fibrillationatrial fibrosisinvestigational drugs

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

83.9K
Robotic Ablation of Atrial Fibrillation11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.8K

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
163
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
57
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
46
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.4K